Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 8/2006

01-08-2006 | Original Paper

Assessment of Portal Hemodynamics by Doppler Ultrasound and of Liver Morphology in the Hepatosplenic and Hepatointestinal Forms of Schistosomiasis Mansoni

Authors: Denise Cerqueira Paranaguá Vezozzo, Alberto Queiroz Farias, Giovanni Guido Cerri, Luiz Caetano Da Silva, Flair José Carrilho

Published in: Digestive Diseases and Sciences | Issue 8/2006

Login to get access

Abstract

The aim of this study was to compare portal and splenic blood flows and the liver morphology in hepatosplenic (HS) and hepatointestinal (HI) schistosomiasis. Doppler ultrasound measurements were performed in 48 adult patients with schistosomiasis, according to the criteria of the World Health Organization, and compared with those performed in 20 healthy controls. Portal flow was significantly higher (P < 0.0001) in both HS and HI (2481 ± 1467 and 2159 ± 1446 ml/min, respectively) than in normal individuals (842 ± 322 ml/min). There was no difference in splenic blood flow (822 ± 685 and 458 ± 292 ml/min, respectively) between HS and HI, but these values were significantly higher than those of normal controls (243 ± 94 ml/min). Portal and splenic overflow are found in both the HS and the HI forms of schistosomiasis.
Literature
1.
Chitsulo L, Engels D, Montresor A, Savioli L (2000) The global status of schistosomiasis and its control. Act Trop 77:41–51CrossRef
2.
Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y, Williams GM, McManus DP (2002) Schistosomiasis. N Engl J Med 346:1212–1220PubMedCrossRef
3.
Lyra LG, Rebouças G, Andrade ZA (1976) Hepatitis B surface antigen carrier state in hepatosplenic schistosomiasis. Gastroenterology 71:641–645PubMed
4.
Da Silva LC, Carrilho FJ (1992) Hepatosplenic schistosomiasis: pathophysiology and treatment. Gastroenterol Clin North Am 21:163–177PubMed
5.
Bogliolo L (1957) The anatomical picture of the liver in hepato-splenic schistosomiasis mansoni. Ann Trop Med Parasitol 51:1–14PubMed
6.
Katz N, Chaves A, Pellegrino J (1972) A simple device for a quantitative stool thick–smesh technique in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 14:397–400PubMed
7.
Pinto PL, Amato Neto V, Matsubara L, de Carvalho SA (1988) Intradermal reaction with diluted antigen for the diagnosis of schistosomiasis mansoni: evaluation of sensivity. Rev Hosp Clin Fac Med São Paulo 43:288–290PubMed
8.
Elliot DE (1996) Schistosomiasis: pathophysiology, diagnosis and treatment. Gastroenterol Clin North Am 25:599–625CrossRef
9.
10.
Homeida M, Abdel-Gadir AF, Cheever AW, Bennett JL, Arbab BM, Ibrahium SZ, Abdel-Salam IM, Dafalla AA, Nash TE (1988) Diagnosis of pathologically confirmed Symmers periportal fibrosis by ultrasonography: a prospective blinded study. Am J Trop Med Hyg 36:86–91
11.
Cerri GG, Alves VA, Magalhães A (1984) Hepatosplenic schistosomiasis mansoni: ultrasound manifestations. Radiology 153:777–780PubMed
12.
Richter J, Hatz C, Haussinger D (2003) Ultrasound in tropical and parasitic diseases. Lancet 362:900–902PubMedCrossRef
13.
Cerri GG, Paranaguá-Vezozzo DC (1992) L’ecographye des schistosomiases hépatiques. J EMU 13:31–35
14.
The Cairo Working Group (Jenkims JM, Hatz C) (1992) The use of diagnostic ultrasound in schistosomiasis—attempts at standardization of methodology. Acta Trop 51:45–63CrossRef
15.
Richter J, Domingues AL, Barata CH, Prata AA, Lambertucci JR (2001) Report of the Second Satellite Symposium on ultrasound in schistosomiasis. Mem Inst Oswaldo Cruz 96(Suppl):151–156PubMed
16.
Moriyasu F, Ban N, Nishida O, Nakamura T, Miyake T, Uchino H, Kanematsu Y, Koizumi S (1986) Clinical application of an ultrasonic duplex system in the quantitative measurement of portal blood flow. J Clin Ultrasound 14:579–588PubMedCrossRef
17.
Paranaguá-Vezozzo DC, Cerri GG (1992) Duplex hemodynamic evaluation of hepatosplenic mansoni schistosomiasis. Mem Inst Oswaldo Cruz 87(Suppl 4):149–151
18.
Mies S, Neeto OB, Beer A, Baia CE, Alfieri FJr, Pereira LM, Sette MJ, Raia S (1997) Systemic and hepatic hemodynamics in hepatosplenic manson's schistosomiasis with and without propranolol. Dig Dis Sci 42:751–761PubMedCrossRef
19.
Kashiwagi T, Kamata T, Abe H (1975) Dynamic studies on the portal hemodynamics by scintiphotosplenoportography. Streamline flow in the human portal vein. Gastroenterology 69:1292–1296PubMed
20.
Gawish Y, El-Hammadi HA, Kotb M, Awad AT, Anwar M (2000) Devasculariztion procedure and DSRS: a controled randomized trial on selected haemodynamic portal flow pattern in schistosomal portal hypertension with variceal bleeding. Int Surg 85:325–330PubMed
21.
Martins RD, Szejnfeld J, Lima FG, Ferrari AP (2000) Endoscopic, ultrasonographic and US-Doppler parameters as indicators of variceal bleeding in patients with schistosomiasis. Dig Dis Sci 45:1013–1018PubMedCrossRef
22.
Sacerdoti D, Bolognesi M, Bombonato G, Gatta A (1995) Paraumbilical vein patency in cirrhosis: effects on hepatic hemodynamics evaluated by Doppler sonography. Hepatology 22:1689–1694PubMed
23.
Lambertucci JR, Cota GF, Pinto-Silva RA, Serufo JC, Gerspacher-Lara R, Costa Drumond S, Antunes CM, Nobre V, Rayes A (2001) Hepatosplenic schistosomiasis in field-based studies: a combined clinical and sonographic definition. Mem Inst Oswaldo Cruz Rio de Janeiro 96(Suppl):147–150
24.
Fevery J, Nevens F (2000) Oesophageal varices: assessment of the risk of bleeding and mortality. J Gastroenterol Hepatol 15:842–848PubMedCrossRef
25.
Andrade Z, Prata A (1963) Asymptomatic schistosomiasis studied by needle biopsy of the liver. Am J Trop Med Hyg 12:854–858PubMed
26.
Dimmette RM (1955) Liver biopsy in clinical schistosomiasis; comparison of wedge and needle types. Gastroenterology 29:219–234PubMed
27.
Consensus Conference, Bologna, Italy, 12 September 1989 (1990) The value of Doppler US in the study of hepatic hemodynamics. J Hepatol 10:353–355
28.
Sabba C, Merkel C, Zoli M, Ferraioli G, Gaiani S, Sacerdoti D, Bolondi L (1995) Interobserver and interequipment variability of echo-Doppler examination of the portal vein: effect of a cooperative training program. Hepatology 21:428–433PubMed
29.
Haag K, Rössle M, Ochs A, Huber M, Siegerstetter V, Olschewski M, Berger E, Lu S, Blum HE (1999) Correlation of duplex sonography findings and portal pressure in 375 patients with portal hypertension. AJR Am J Roentgenol 172:631–635PubMed
30.
Endorzain Soza JC, Martin Hervas C, Moreno Blanco MA, Zapata Aparicio I, Herrera Abian A, Conde Gacho P, Madero R, Segura Cabral JM (2000) Color duplex Doppler ultrasonography in the evaluation of the risk of esophageal varices bleeding in cirrhotic patients. Gastroenterologia y Hepatologia 23:466–469
31.
Zironi G, Gaiani S, Fenyves D, Rigamonti A, Bolondi L, Barbara L (1992) Value of measurement of mean portal flow velocity by Doppler flowmetry in the diagnosis of portal hypertension. J Hepatol 16:298–303PubMedCrossRef
32.
Zoli M, Marchesini G, Cordiani MR, Pisi P, Brunori A, Trono A, Pisi E (1986) Echo-Doppler measurement of splanchnic blood flow in control and cirrhotic subjects. J Clin Ultrasound 14:429–435PubMedCrossRef
33.
Siringo S, Bolondi L, Gaiani S, Sofia S, Febo G, Zironi G, Rigamonti A, Miglioni M, Cavalli G, Barbara L (1994) The relationship of endoscopy, portal Doppler ultrasound flowmetry, and clinical and biochemical tests in cirrhosis. J Hepatol 20:11–18PubMedCrossRef
Metadata
Title
Assessment of Portal Hemodynamics by Doppler Ultrasound and of Liver Morphology in the Hepatosplenic and Hepatointestinal Forms of Schistosomiasis Mansoni
Authors
Denise Cerqueira Paranaguá Vezozzo
Alberto Queiroz Farias
Giovanni Guido Cerri
Luiz Caetano Da Silva
Flair José Carrilho
Publication date
01-08-2006
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2006
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-005-9020-1

Other articles of this Issue 8/2006

Digestive Diseases and Sciences 8/2006 Go to the issue

Original Paper

Epidermal Growth Factor Enhances Intracellular pH Regulation via Calcium Signaling in Acid-Exposed Primary Cultured Rabbit Gastric Epithelial Cells

Original Paper

Hyperbaric Oxygenation Ameliorates Indomethacin-Induced Enteropathy in Rats by Modulating TNF-α and IL-1β Production

Original Paper

Exogenous Adenosine Triphosphate and Adenosine Stimulate Proximal Sphincter of Oddi Motility Via Neural Mechanisms in the Anesthetized Australian Possum

Original Paper

No Debridement Is Necessary for Symptomatic or Infected Acute Necrotizing Pancreatitis: Delayed, Mini-Retroperitoneal Drainage for Acute Necrotizing Pancreatitis Without Debridement and Irrigation

Original Paper

Effects of Saccharomyces boulardii on Intestinal Mucosa

Original Paper

Predictors of Clinical Response to Systemic Steroids in Active Ulcerative Colitis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits